About
Our Mission is to ensure the best possible treatment for every cancer patient.
Picture Health develops multimodal AI-powered biomarkers and actively collaborates with academic institutions and biopharma to drive innovation in oncology and enable optimal treatment selection for patients and care teams. Our team of experts, including researchers, scientists, medical professionals, and startup veterans, has created interpretable AI biomarkers from standard radiology scans, pathology images, and other clinical data. These biomarkers can be used throughout a patient’s cancer journey: from clinical trial cohorts to treatment selection and response monitoring.
What is Px?
Picture Health’s Px™ Platform leverages a proprietary Feature Library to quantify tumor properties and build custom biomarkers quickly, and without the need for large datasets.
These new insights allow for better and earlier response prediction as well as improved patient characterization and selection. By using routine clinical imaging and other data, Px eliminates the need for additional tissue or esoteric testing, which allows the creation of AI biomarkers for all current and retrospective oncology trials. Px builds on a decade of scientific AI health imaging research. Taking advantage of the latest advancements in digitization and AI to analyze biologically relevant features that cannot be quantified manually to provide a deeper characterization of the tumor and its surrounding environment.